Biovie Inc.
BIVI· Nasdaq
BIVIBiovie Inc.
Filed Nov 8, 2023 · 10-Q · 39 days after period end · 0001520138-23-000473
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Net Income | -$10.71M | -$10.42M | -$5.54M | $7.33M |
| EPS Diluted | -$2.92 | -$0.38 | -$0.23 | -$7.75 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biovie Inc. · CIK 1580149 · Engraved from SEC EDGAR
ended Sep 30, 2023 · filed Nov 8, 2023 · 39 d after period end
